Many people have a genetic predisposition to obesity, but gene defects that guarantee obesity are rare. Here's what you need ...

Adult obesity is rising in the United States, with a greater impact on racial and ethnic minorities, a U.S. Centers for Disease Control (CDC) report showed, at a time when the health condition is seen ...

Obesity has been linked to diseases like diabetes, heart disease, and hypertension for a long time. Excess weight is now ...

Researchers conducted a cross-sectional analysis utilizing data from the 2019 National Survey of Children’s Health to assess the link between household food insecurity and obesity in US adolescents. A ...

Obesity remains a major public health challenge in the United States, affecting more than one-third of adults and contributing to a wide range of chronic conditions, including heart disease, diabetes, ...

Aussies eat more ultra-processed foods than ever before, with busy lifestyles and personal choices often taking the blame as ...

Novo Nordisk is set to buy US liver disease biotech Akero Therapeutics for up to $5.2bn, as the Danish drugmaker seeks to ...

Novo Nordisk A/S plans to seek US regulatory approval for a high-dose version of its blockbuster weight-loss shot Wegovy, another effort to counter Eli Lilly & Co. in the booming obesity market.

Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy ®) achieved significant weight loss, with one in three study participants losing 20% or more body weight 1 ** Oral semaglutide 25 mg ...